ReviewFrontiers in genome editing2026
Harnessing myostatin pleiotropy for multitrait improvement via precision gene editing.
Review in Frontiers in genome editing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Production of gene-edited cloned cattle embryos using the CRISPR/EOCas12i system.Frontiers in genome editing · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pursuit of sustainable livestock farming to meet the rising global protein demand has positioned myostatin (MSTN) gene editing as a key technology. However, the field's focus on the remarkable double-muscle phenotype has often overshadowed a systematic examination of its concomitant effects. The present review aims to bridge this gap by moving beyond a singular focus on productivity. First, the pleiotropic effects of MSTN gene editing on growth performance, carcass quality, and meat quality in cattle, swine, sheep, poultry, and aquatic species were comprehensively evaluated. Next, the cascading biological effects of MSTN editing on metabolic homeostasis, reproductive performance, and animal health and welfare werAAe analyzed in depth. Finally, the inherent limitations and ethical issues of current editing techniques were critically discussed, and future sustainable breeding programs aimed at balanced multitrait regulation were prospectively proposed. Ultimately, this review affirms that MSTN editing has a multiplicative effect on trait alterations; however, there is also a series of associated health challenges, which demonstrates that the technology's impact is systemic, generating a spectrum of trade-offs that are often species specific. Its responsible application therefore hinges on multitrait balancing strategies to simultaneously secure productivity and sustainability in animal agriculture.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.